| Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients A Scarpa, W Mantovani, P Capelli, S Beghelli, L Boninsegna, R Bettini, ... Modern Pathology 23 (6), 824-833, 2010 | 539 | 2010 |
| Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization F Panzuto, S Nasoni, M Falconi, VD Corleto, G Capurso, S Cassetta, ... Endocrine-related cancer 12 (4), 1083-1092, 2005 | 478 | 2005 |
| Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression F Panzuto, L Boninsegna, N Fazio, D Campana, M Pia Brizzi, G Capurso, ... Journal of Clinical Oncology 29 (17), 2372-2377, 2011 | 324 | 2011 |
| Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections L Boninsegna, F Panzuto, S Partelli, P Capelli, G Delle Fave, R Bettini, ... European Journal of Cancer 48 (11), 1608-1615, 2012 | 189 | 2012 |
| Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study A Larghi, G Capurso, A Carnuccio, R Ricci, S Alfieri, D Galasso, F Lugli, ... Gastrointestinal endoscopy 76 (3), 570-577, 2012 | 184 | 2012 |
| Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate E Merola, A Sbrozzi-Vanni, F Panzuto, G D’Ambra, E Di Giulio, E Pilozzi, ... Neuroendocrinology 95 (3), 207-213, 2012 | 166 | 2012 |
| Endocrine tumours of the stomach G Delle Fave, G Capurso, M Milione, F Panzuto Best practice & research Clinical gastroenterology 19 (5), 659-673, 2005 | 117 | 2005 |
| Real-world study of everolimus in advanced progressive neuroendocrine tumors F Panzuto, M Rinzivillo, N Fazio, F de Braud, G Luppi, MC Zatelli, F Lugli, ... The oncologist 19 (9), 966-974, 2014 | 109 | 2014 |
| Molecular pathology and genetics of pancreatic endocrine tumours. G Capurso, S Festa, R Valente, M Piciucchi, F Panzuto, RT Jensen, ... Journal of molecular endocrinology 49 (1), R37-50, 2012 | 106 | 2012 |
| Can patient characteristics predict the outcome of endoscopic evaluation of iron deficiency anemia: a multiple logistic regression analysis G Capurso, F Baccini, J Osborn, F Panzuto, E Di Giulio, G Delle Fave, ... Gastrointestinal endoscopy 59 (7), 766-771, 2004 | 73 | 2004 |
| Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells A Di Florio, G Capurso, M Milione, F Panzuto, R Geremia, G Delle Fave, ... Endocrine-Related Cancer 14 (1), 111-124, 2007 | 69 | 2007 |
| Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome F Panzuto, E Merola, M Rinzivillo, S Partelli, D Campana, E Iannicelli, ... Pancreas 43 (2), 212-218, 2014 | 68 | 2014 |
| Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas VD Corleto, M Falconi, F Panzuto, M Milione, O De Luca, P Perri, ... Neuroendocrinology 89 (2), 223-230, 2009 | 68 | 2009 |
| The role of combined 68Ga-DOTANOC and 18FDG PET/CT in the management of patients with pancreatic neuroendocrine tumors S Partelli, M Rinzivillo, A Maurizi, F Panzuto, M Salgarello, V Polenta, ... Neuroendocrinology 100 (4), 293-299, 2015 | 62 | 2015 |
| Gastric neuroendocrine tumors G Delle Fave, G Capurso, B Annibale, F Panzuto Neuroendocrinology 80 (Suppl. 1), 16-19, 2004 | 62 | 2004 |
| Risk factors for sporadic pancreatic endocrine tumors: a case-control study of prospectively evaluated patients G Capurso, M Falconi, F Panzuto, M Rinzivillo, L Boninsegna, R Bettini, ... Official journal of the American College of Gastroenterology| ACG 104 (12 …, 2009 | 60 | 2009 |
| Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence D Campana, G Capurso, S Partelli, F Nori, F Panzuto, D Tamburrino, ... European journal of nuclear medicine and molecular imaging 40, 1197-1205, 2013 | 59 | 2013 |
| Risk factors for disease progression in advanced jejunoileal neuroendocrine tumors F Panzuto, D Campana, N Fazio, MP Brizzi, L Boninsegna, F Nori, ... Neuroendocrinology 96 (1), 32-40, 2012 | 59 | 2012 |
| Nasogastric or nasointestinal feeding in severe acute pancreatitis M Piciucchi, E Merola, M Marignani, M Signoretti, R Valente, L Cocomello, ... World journal of gastroenterology: WJG 16 (29), 3692, 2010 | 51 | 2010 |
| Molecular target therapy for gastroenteropancreatic endocrine tumours: biological rationale and clinical perspectives G Capurso, N Fazio, S Festa, F Panzuto, F De Braud, G Delle Fave Critical reviews in oncology/hematology 72 (2), 110-124, 2009 | 49 | 2009 |
